Clinical Trials · NCT07592546

Translational Health Research Into Vascular and Neurocognitive Effects of Weight Loss

Phase
Phase 4
Recruitment status
Recruiting
Sponsor
Alain Dagher
Enrollment
240
Start date
Oct 2026
Locations
1 site, Canada
Primary endpoint
Serum C-reactive Protein (CRP)
View Semaglutide compound reference